Cargando…

TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway

BACKGROUND: Transforming growth factor β(1)-activated kinase 1 binding protein 2 (TAB2) mediates a variety of biological processes through activated nuclear factor κ-light-chain-enhancer of activated B cell (NF-κB) signaling pathways. TAB2 has been reported to be upregulated in a variety of tumors....

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Huijuan, Zhang, Hui, Fan, Haidong, Tang, Su, Weng, Junquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377915/ https://www.ncbi.nlm.nih.gov/pubmed/35978886 http://dx.doi.org/10.1155/2022/1217918

Ejemplares similares

YTHDC1 Promotes Stemness Maintenance and Malignant Progression in Head and Neck Squamous Cell Carcinoma
por: Weng, Junquan, et al.
Publicado: (2022)

KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma
por: Ingruber, Julia, et al.
Publicado: (2021)

Dysregulations in the PI3K pathway and targeted therapies for head and neck squamous cell carcinoma
por: Cai, Yi, et al.
Publicado: (2017)

TAB2 Promotes the Stemness and Biological Functions of Cervical Squamous Cell Carcinoma Cells
por: Zhou, Yijia, et al.
Publicado: (2021)

Construction of a combined hypoxia and EMT index for head and neck squamous cell carcinoma
por: Li, Huan, et al.
Publicado: (2022)

Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)
por: Jung, Kyungsuk, et al.
Publicado: (2018)

DDB2 regulates Epithelial-to-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell Carcinoma
por: Bommi, Prashant V., et al.
Publicado: (2018)

PI3K pathway mutation predicts an activated immune microenvironment and better immunotherapeutic efficacy in head and neck squamous cell carcinoma
por: Wang, Libo, et al.
Publicado: (2023)

Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy
por: Chuang, Fu-Cheng, et al.
Publicado: (2021)

Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas
por: Su, Yu-Chieh, et al.
Publicado: (2022)

Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas
por: García-Carracedo, Darío, et al.
Publicado: (2016)

TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma
por: Chen, Lei, et al.
Publicado: (2017)

Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma
por: Mizrachi, Aviram, et al.
Publicado: (2017)

Hypermethylation of PRKCZ Regulated by E6 Inhibits Invasion and EMT via Cdc42 in HPV-Related Head and Neck Squamous Cell Carcinoma
por: Wang, Hao-Fan, et al.
Publicado: (2022)

LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus
por: Jiang, Yingying, et al.
Publicado: (2019)

EMT-related transcription factors and protein stabilization mechanisms involvement in cadherin switch of head and neck squamous cell carcinoma
por: Ingruber, Julia, et al.
Publicado: (2022)

Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma
por: Guan, Jian, et al.
Publicado: (2021)

Metadherin Regulation of Vascular Endothelial Growth Factor Expression Is Dependent Upon the PI3K/Akt Pathway in Squamous Cell Carcinoma of the Head and Neck
por: Zhu, Gang-cai, et al.
Publicado: (2015)

Abnormal Decrease of Macrophage ALKBH5 Expression Causes Abnormal Polarization and Inhibits Osteoblast Differentiation
por: Weng, Junquan, et al.
Publicado: (2023)

Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
por: Ruicci, Kara M., et al.
Publicado: (2019)

Knockdown of HPIP Inhibits the Proliferation and Invasion of Head-and-Neck Squamous Cell Carcinoma Cells by Regulating PI3K/Akt Signaling Pathway
por: Chen, Yangjing, et al.
Publicado: (2016)

Multiparameter Analysis, including EMT Markers, on Negatively Enriched Blood Samples from Patients with Squamous Cell Carcinoma of the Head and Neck
por: Balasubramanian, Priya, et al.
Publicado: (2012)

Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR-26a-5p
por: Hu, Weiming, et al.
Publicado: (2021)

Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma
por: Erlich, R B, et al.
Publicado: (2012)

STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling
por: Yang, Shuwen, et al.
Publicado: (2016)

Dual Inhibition of Autophagy and PI3K/AKT/MTOR Pathway as a Therapeutic Strategy in Head and Neck Squamous Cell Carcinoma
por: Bernard, Monique, et al.
Publicado: (2020)

Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma
por: Choonoo, Gabrielle, et al.
Publicado: (2019)

The influence of PI3K inhibition on the radiotherapy response of head and neck cancer cells
por: Glorieux, Mary, et al.
Publicado: (2020)

G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma
por: Liu, Shuli, et al.
Publicado: (2015)

CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway
por: Jia, Wenming, et al.
Publicado: (2023)

Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
por: Ruicci, Kara M., et al.
Publicado: (2019)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma
por: Fukusumi, Takahito, et al.
Publicado: (2020)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rqnon1gipdsr9bi1k21jj78v2v